X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-18 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale | $14.05 | -12,000 | 139,437 | -8% | -$168,600 | ||||||
A | 2024-02-01 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale | $15.78 | -3,789 | 151,437 | -2% | -$59,790 | |||||
D | 2024-01-31 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale+OE | $15.74 | -3,789 | 151,437 | -2% | -$59,639 | |||||
D | 2023-01-31 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale+OE | $10.12 | -1,900 | 148,560 | -1% | -$19,228 | |||||
D | 2022-10-31 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale+OE | $11.85 | -258 | 23,950 | -1% | -$3,057 | |||||
D | 2022-08-01 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale+OE | $7.81 | -259 | 23,708 | -1% | -$2,023 | |||||
D | 2022-04-30 | URGN | Schoenberg Mark | Chief Medical Officer | S - Sale+OE | $6.62 | -254 | 23,467 | -1% | -$1,681 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |